Status:
COMPLETED
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
Lead Sponsor:
Line Cleemann
Collaborating Sponsors:
Novo Nordisk A/S
The County of Frederiksborg
Conditions:
Turner Syndrome
Eligibility:
FEMALE
10-25 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine whether a larger dosage of estrogen than the one used today will secure the development of a normal sized uterus and increase the strength of the bones in girls...
Detailed Description
Turner syndrome is a common chromosomal disorder with only one X-chromosome or partial deletions in one X-chromosome in all or some of the cell-lines in the body. Appr. 18 girls/year are being born wi...
Eligibility Criteria
Inclusion
- Verified Turner syndrome
- Ages 10-25 years
Exclusion
- Contraindications to the MR-scan
- Contraindications to the trial medication
- Severe or chronic sickness with impact on the parameters of the study or incompatibility with the trial medication
- Intake of medications with interactions with trial medication
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00134745
Start Date
June 1 2005
End Date
March 1 2013
Last Update
June 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Unit, Hillerod Hospital
Hillerød, Frederiksborg County, Denmark, 4300